What it is
Stem cells are cells that can divide and develop into other kinds of cells. Because of this ability, they have drawn great interest in medicine. The same ability to multiply and change is also why scientists study them carefully for safety, including whether cells could grow in unintended ways.
Reports in the medical literature and public warnings from the FDA describe real risk categories linked to unapproved stem cell products. These include infection, immune reaction, tumor formation at or near the injection site, and permanent injury when unapproved products are injected into the eye or spine. This page does not give rates, because the risks differ by product, source and how a product is made and handled.
The regulatory status matters here. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use. Stem cell, MSC, bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved stem cell clinics and products.
How it’s traditionally been approached
Medicine has long approached cell-based care through carefully controlled settings. Blood-forming stem cell transplants have a long track record in treating certain cancers and blood disorders, with matching, monitoring and follow-up built into the process.
For conditions such as joint pain, back pain, sports injuries, skin concerns or hair loss, care has traditionally relied on approaches such as physical therapy, exercise, medications, bracing, lifestyle changes and, when appropriate, procedures that have gone through standard regulatory review. A licensed clinician decides what fits a given person after an evaluation.
New cell-based treatments are typically studied in registered clinical trials before they are approved. These trials have oversight, defined safety monitoring and informed consent processes. ClinicalTrials.gov is a public registry where people can search for such studies in general terms.
How the right provider may help
The right provider may help you sort through the safety questions before you decide anything. A visit with a licensed physician, such as someone in orthopedics and sports medicine or a regenerative and wellness medicine clinic, generally starts with your history, your symptoms and an exam. Imaging or other tests may be discussed if the clinician thinks they are appropriate.
It is reasonable to ask the provider directly: What exact product would be used, and where does it come from? What is its FDA status for my condition? What are the specific risks, including tumor formation, infection and immune reaction? What is the realistic chance of benefit? What are the alternatives, including doing nothing? A trustworthy provider should be willing to answer plainly and in writing.
A provider may also talk with you about established options and whether a registered clinical trial could be a legitimate route to experimental care. Getting a second opinion is normal and reasonable. If the first provider discourages it, treat that as a signal to slow down.
The whole-person view
Body, mind and stress affect each other. Ongoing pain or a hard-to-treat condition can wear on your sleep, mood and sense of hope, and those feelings can make a promise of a quick fix sound very appealing. Being aware of that pull can help you make calmer, better-informed choices.
Body-based support such as that from Somatic Experiences practitioners may help some people work with stress and tension that accompany chronic discomfort. Talk therapy through a resource like Therapists.plus may help with the worry, frustration or decision fatigue that can come with a medical search. These are supportive options to discuss with your care team, not substitutes for medical evaluation.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- Most stem cell products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved clinics and products.
- Red flags include guarantees of results, words like "cure" or "regrow," refusal to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion.
- Treatment abroad (medical tourism) carries materially higher risk because safety, sourcing and regulatory standards differ and complications are harder to address from a distance; a vetted domestic provider is a safer first step. Informed consent should cover the exact product and FDA status, specific risks, realistic chance of benefit, alternatives including doing nothing, total cost disclosure and your right to walk away. This page is not a consent form.
- Licensed professionals should guide care for serious conditions. For emergencies call 911; in a crisis call or text 988. To report a suspected problem, you can file a report through the FDA's MedWatch safety reporting program and contact your state medical board.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
Can stem cell injections cause tumors?
Tumor formation at the injection site is one of the risk categories reported with unapproved stem cell products. The likelihood depends on the product and how it is made and handled, and this page gives no rates. Ask a licensed clinician about the specific product and its FDA status.
Is tumor risk from stem cell injection well understood?
Not fully for many unapproved products, which is part of why the FDA has issued public warnings. Products that have not gone through standard FDA review have not been shown to meet its safety and effectiveness standards for those uses. A provider should be honest about what is and is not known.
Are stem cell injections for knees, back pain or hair loss FDA-approved?
Generally no. Stem cell, MSC, bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses. The clearly approved use is blood-forming stem cell transplants from cord blood or bone marrow for certain cancers and blood disorders.
What are the red flags of an unsafe stem cell clinic?
Warning signs include guaranteed results, claims to "cure" or "regrow" tissue, refusing to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion. Vague answers about where the cells come from are also a concern. If you see these, pause and consult an independent licensed clinician.
How do I report a problem after a stem cell injection?
Seek care from a licensed clinician first, and call 911 in an emergency. You can then report a suspected problem through the FDA's MedWatch safety reporting program and file a complaint with your state medical board. Keep records of the product, the provider and your symptoms.
Is there a safer way to access experimental stem cell treatment?
A registered clinical trial is a legitimate route to experimental care, with oversight and informed consent. You can search ClinicalTrials.gov generically for studies related to your condition and discuss them with your doctor. A vetted domestic provider is generally a safer first step than treatment abroad.
Educational resource. Safe Stem Cells shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.